Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1344307
                    [Title] => Access program helps poor cancer patients get treatment
                    [Summary] => 
A patient support group has lauded Novartis Healthcare Philippines for its unprecedented access program that helps underprivileged patients get the cancer treatments they need.

                    [DatePublished] => 2014-07-10 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Max-Philippines-Novartis-Healthcare.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 464588
                    [Title] => Reducing risk of cancer returning in patients
                    [Summary] => 
MANILA,  Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

NOVARTIS ONCOLOGY ACCESS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1344307
                    [Title] => Access program helps poor cancer patients get treatment
                    [Summary] => 
A patient support group has lauded Novartis Healthcare Philippines for its unprecedented access program that helps underprivileged patients get the cancer treatments they need.

                    [DatePublished] => 2014-07-10 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Max-Philippines-Novartis-Healthcare.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 464588
                    [Title] => Reducing risk of cancer returning in patients
                    [Summary] => 
MANILA,  Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Access program helps poor cancer patients get treatment

July 10, 2014 - 12:00am

A patient support group has lauded Novartis Healthcare Philippines for its unprecedented access program that helps underprivileged...

Science and Environment

Reducing risk of cancer returning in patients

May 7, 2009 - 12:00am

MANILA, Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal...

Science and Environment